欧洲呼吸学会
期刊
会议
图书
作者:Marc Humbert , Nicholas W. Morrell ...
来源:[J].European Respiratory Journal(IF 6.355), 2020, Vol.55 (2)
摘要:Pulmonary arterial hypertension (PAH) is a rare disease that leads to premature death from right heart failure. It is strongly associated with elevated red cell distribution width (RDW), a correlate of several iron status biomarkers. High RDW values can signal early-stage ir...
作者:Marc Humbert , Thomas Similowski ...
来源:[J].European Respiratory Journal(IF 6.355), 2020, Vol.55 (2)
摘要:Dynamic hyperinflation is observed during exercise in 60% of patients with clinically stable pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), intensifying exertional dyspnoea. The impact of dynamic changes in respiratory mechan...
作者:Marc Humbert , Camille Taillé ...
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.51 (5)
摘要:Omalizumab is a monoclonal anti-IgE antibody used to treat severe allergic asthma (SAA). The aim of the STELLAIR study was to determine the importance of pre-treatment blood eosinophil count as a predictive measure for response to omalizumab.(#br)This retrospective real-life...
作者:Marc Humbert , Thomas O. Wagner
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.49 (2)
摘要:Rare diseases are life-threatening or chronically debilitating conditions which are of such low prevalence (fewer than 1 in 2000 people) that special combined efforts are needed to address them [1]. Launched in 2008 by Rare Diseases Europe (EURORDIS), a non-governmental patient-d...
作者:Marc Humbert , Jason Weatherald
来源:[J].European Respiratory Journal(IF 6.355), 2018, Vol.52 (1)
摘要:For patients with pulmonary arterial hypertension (PAH), the most recent European guidelines state that right heart catheterisation (RHC) is mandatory for confirming the diagnosis of PAH, and that RHC should be considered 3–6 months after therapy changes and in patients who ...
作者:Marc Humbert , Christophe Guignabert ...
来源:[J].European Respiratory Journal(IF 6.355), 2019, Vol.53 (1)
摘要:Clinical and translational research has played a major role in advancing our understanding of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms of PH with severe vascular remodelling ( e.g. chronic thromboembolic PH and pulmonary veno-occlusiv...
作者:Marc Humbert , Anh Tuan Dinh-Xuan ...
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.49 (1)
摘要:Happy New Year! As 2017 begins, so too does the final year of the current editorial board's mandate. Welcome to our annual look back at some of the highlights of our past 12 months of publishing, and forward to some of the new developments 2017 will see for the European Respirato...
作者:Marc Humbert , Harrison W. Farber ...
来源:[J].European Respiratory Journal(IF 6.355), 2019, Vol.53 (6)
摘要:Background(#br)Current pulmonary hypertension treatment guidelines recommend use of a risk stratification model encompassing a range of parameters, allowing patients to be categorised as low, intermediate or high risk. Three abbreviated versions of this risk stratification model ...
作者:Marc Humbert , Olivier Sitbon
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.50 (4)
摘要:Studies reporting the effects of modern strategies with pulmonary arterial hypertension (PAH)-targeted therapies in sarcoidosis-associated pulmonary hypertension (S-APH) are limited.(#br)Clinical and haemodynamic data from newly diagnosed patients with severe S-APH (mean pul...
作者:... Hossam Haick , Marc Humbert , Sylvia Cohen-Kaminsky
来源:[J].European Respiratory Journal(IF 6.355), 2017, Vol.49 (2)
摘要:There is accumulating evidence in support of the significant improvement in survival rates and clinical outcomes when pulmonary arterial hypertension (PAH) is diagnosed at early stages. Nevertheless, it remains a major clinical challenge and the outcomes are dependent on inv...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×